https://www.odipharma.com/post/approvedforlisting "Company has secured a valuable supply contract through its relationship with one of the largest cannabis producers in Canada, Aphria Inc. The Company intends to provide a range of medical cannabis products which, due to the regulation in Poland, will initially be dried flowers.
ODI Pharma intends to formulate its first order of raw cannabis material from Aphria in early 2020, meaning that the Company intends to start operations on the Polish strategy, starting with educational programs, in early 2020"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.